Ultragenyx

MEPSEVII

Manufacturer:

Ultragenyx

Mepsevii HCPCS:

J3397

HCPCS Code Descriptor:

Injection, vestronidase alfa-vjbk, 1 mg

Category:

J Code

Mepsevii NDCs:

69794-0001-01

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Mepsevii:

MEPSEVII is an Enzyme Replacement Therapy drug manufactured by Ultragenyx and administered via the Intravenous route of administration. The J Code: J3397 is aligned to the drug MEPSEVII.

ACCESS PRICING AND MORE BY REGISTERING

J3397 Added Date:

January 1, 2019

J3397 Effective Date:

January 1, 2019

J3397 Termination Date:

HCPCS Active

Mepsevii billing and coding information can be found through Ultragenyx at the link below:
Mepsevii patient assistance information can be found through UltraCare at the URL: https://www.ultracaresupport.com/patient-services/
MEPSEVII prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for MEPSEVII. Please check back in a few weeks.